1. Executive Summary
1.1. Global Dengue Testing Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Economic Overview
2.6.1. World Economic Projections
2.7. PESTLE Analysis
3. Global Dengue Testing Market Outlook, 2018 - 2031
3.1. Global Dengue Testing Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
3.1.1. Key Highlights
3.1.1.1. ELISA-based Tests
3.1.1.2. RT-PCR based Tests
3.1.1.3. Dengue IgG/IgM Rapid Test
3.2. Global Dengue Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
3.2.1. Key Highlights
3.2.1.1. Hospitals
3.2.1.2. Public Health Laboratory
3.2.1.3. Diagnostic Centers
3.2.1.4. Others
3.3. Global Dengue Testing Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
3.3.1. Key Highlights
3.3.1.1. North America
3.3.1.2. Europe
3.3.1.3. Asia Pacific
3.3.1.4. Latin America
3.3.1.5. Middle East & Africa
4. North America Dengue Testing Market Outlook, 2018 - 2031
4.1. North America Dengue Testing Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
4.1.1. Key Highlights
4.1.1.1. ELISA-based Tests
4.1.1.2. RT-PCR based Tests
4.1.1.3. Dengue IgG/IgM Rapid Test
4.2. North America Dengue Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
4.2.1. Key Highlights
4.2.1.1. Hospitals
4.2.1.2. Public Health Laboratory
4.2.1.3. Diagnostic Centers
4.2.1.4. Others
4.3. North America Dengue Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
4.3.1. Key Highlights
4.3.1.1. U.S. Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
4.3.1.2. U.S. Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
4.3.1.3. Canada Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
4.3.1.4. Canada Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
4.3.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Dengue Testing Market Outlook, 2018 - 2031
5.1. Europe Dengue Testing Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
5.1.1. Key Highlights
5.1.1.1. ELISA-based Tests
5.1.1.2. RT-PCR based Tests
5.1.1.3. Dengue IgG/IgM Rapid Test
5.2. Europe Dengue Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
5.2.1. Key Highlights
5.2.1.1. Hospitals
5.2.1.2. Public Health Laboratory
5.2.1.3. Diagnostic Centers
5.2.1.4. Others
5.3. Europe Dengue Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
5.3.1. Key Highlights
5.3.1.1. Germany Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
5.3.1.2. Germany Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
5.3.1.3. U.K. Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
5.3.1.4. U.K. Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
5.3.1.5. France Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
5.3.1.6. France Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
5.3.1.7. Italy Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
5.3.1.8. Italy Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
5.3.1.9. Turkey Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
5.3.1.10. Turkey Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
5.3.1.11. Russia Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
5.3.1.12. Russia Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
5.3.1.13. Rest of Europe Dengue Testing Market by Product Type, Value (US$Bn), 2018 - 2031
5.3.1.14. Rest of Europe Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
5.3.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Dengue Testing Market Outlook, 2018 - 2031
6.1. Asia Pacific Dengue Testing Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
6.1.1. Key Highlights
6.1.1.1. ELISA-based Tests
6.1.1.2. RT-PCR based Tests
6.1.1.3. Dengue IgG/IgM Rapid Test
6.2. Asia Pacific Dengue Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
6.2.1. Key Highlights
6.2.1.1. Hospitals
6.2.1.2. Public Health Laboratory
6.2.1.3. Diagnostic Centers
6.2.1.4. Others
6.2.2. BPS Analysis/Market Attractiveness Analysis
6.3. Asia Pacific Dengue Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
6.3.1. Key Highlights
6.3.1.1. China Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
6.3.1.2. China Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
6.3.1.3. Japan Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
6.3.1.4. Japan Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
6.3.1.5. South Korea Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
6.3.1.6. South Korea Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
6.3.1.7. India Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
6.3.1.8. India Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
6.3.1.9. Southeast Asia Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
6.3.1.10. Southeast Asia Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
6.3.1.11. Rest of Asia Pacific Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
6.3.1.12. Rest of Asia Pacific Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
6.3.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Dengue Testing Market Outlook, 2018 - 2031
7.1. Latin America Dengue Testing Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
7.1.1. Key Highlights
7.1.1.1. ELISA-based Tests
7.1.1.2. RT-PCR based Tests
7.1.1.3. Dengue IgG/IgM Rapid Test
7.2. Latin America Dengue Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
7.2.1.1. Hospitals
7.2.1.2. Public Health Laboratory
7.2.1.3. Diagnostic Centers
7.2.1.4. Others
7.2.2. BPS Analysis/Market Attractiveness Analysis
7.3. Latin America Dengue Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
7.3.1. Key Highlights
7.3.1.1. Brazil Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
7.3.1.2. Brazil Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
7.3.1.3. Mexico Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
7.3.1.4. Mexico Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
7.3.1.5. Argentina Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
7.3.1.6. Argentina Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
7.3.1.7. Rest of Latin America Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
7.3.1.8. Rest of Latin America Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
7.3.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Dengue Testing Market Outlook, 2018 - 2031
8.1. Middle East & Africa Dengue Testing Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
8.1.1. Key Highlights
8.1.1.1. ELISA-based Tests
8.1.1.2. RT-PCR based Tests
8.1.1.3. Dengue IgG/IgM Rapid Test
8.2. Middle East & Africa Dengue Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
8.2.1. Key Highlights
8.2.1.1. Hospitals
8.2.1.2. Public Health Laboratory
8.2.1.3. Diagnostic Centers
8.2.1.4. Others
8.2.2. BPS Analysis/Market Attractiveness Analysis
8.3. Middle East & Africa Dengue Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
8.3.1. Key Highlights
8.3.1.1. GCC Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
8.3.1.2. GCC Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
8.3.1.3. South Africa Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
8.3.1.4. South Africa Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
8.3.1.5. Egypt Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
8.3.1.6. Egypt Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
8.3.1.7. Nigeria Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
8.3.1.8. Nigeria Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
8.3.1.9. Rest of Middle East & Africa Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
8.3.1.10. Rest of Middle East & Africa Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
8.3.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. By Product vs by End User Heatmap
9.2. Company Market Share Analysis, 2023
9.3. Competitive Dashboard
9.4. Company Profiles
9.4.1. Thermo Fisher Scientific Inc.
9.4.1.1. Company Overview
9.4.1.2. Therapy Portfolio
9.4.1.3. Financial Overview
9.4.1.4. Business Strategies and Development
9.4.2. Roche Molecular Systems Inc.
9.4.2.1. Company Overview
9.4.2.2. Therapy Portfolio
9.4.2.3. Financial Overview
9.4.2.4. Business Strategies and Development
9.4.3. Abbott Laboratories
9.4.3.1. Company Overview
9.4.3.2. Therapy Portfolio
9.4.3.3. Financial Overview
9.4.3.4. Business Strategies and Development
9.4.4. InBios International, Inc.
9.4.4.1. Company Overview
9.4.4.2. Therapy Portfolio
9.4.4.3. Financial Overview
9.4.4.4. Business Strategies and Development
9.4.5. NovaTec Immundiagnostica GmbH
9.4.5.1. Company Overview
9.4.5.2. Therapy Portfolio
9.4.5.3. Financial Overview
9.4.5.4. Business Strategies and Development
9.4.6. Quest Diagnostics
9.4.6.1. Company Overview
9.4.6.2. Therapy Portfolio
9.4.6.3. Financial Overview
9.4.6.4. Business Strategies and Development
9.4.7. Certest Biotec S.L.
9.4.7.1. Company Overview
9.4.7.2. Therapy Portfolio
9.4.7.3. Financial Overview
9.4.7.4. Business Strategies and Development
9.4.8. OriGene Technologies
9.4.8.1. Company Overview
9.4.8.2. Therapy Portfolio
9.4.8.3. Financial Overview
9.4.8.4. Business Strategies and Development
9.4.9. Abnova Corporation
9.4.9.1. Company Overview
9.4.9.2. Therapy Portfolio
9.4.9.3. Financial Overview
9.4.9.4. Business Strategies and Development
9.4.10. Others
9.4.10.1. Company Overview
9.4.10.2. Therapy Portfolio
9.4.10.3. Financial Overview
9.4.10.4. Business Strategies and Development
10. Appendix
10.1.Research Methodology
10.2.Report Assumptions
10.3.Acronyms and Abbreviations